Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study

International Journal of Impotence Research volume 22, pages 115–119 (2010)Cite this article

Abstract

Phosphodiesterase type 5 inhibitors were initially approved for the treatment of erectile dysfunction in men and were later suggested for some systemic disorders, mostly due to their possible beneficial effects on endothelial functions. Paradoxically, though, phosphodiesterase type 5 inhibitors may have some life-threatening effects, for which there is weak evidence, it appears that they are associated with cardiovascular problems such as myocardial infarction and stroke. This study aimed to investigate the acute effects of tadalafil citrate on the cardiovascular system by evaluating serum oxidative status and paraoxonase-1 activity. Sera of 36 patients with erectile dysfunction were analyzed for total antioxidant status, total oxidant status and paraoxonase-1, before and after the administration of tadalafil citrate. Pre- and post-tadalafil citrate serum levels of total antioxidants, total oxidants and paraoxonase-1 were 1.1±0.0 and 1.6±0.0 μmol H2O2 equiv l−1, 10.3±1.1 and 6.9±1.2 μmol H2O2 equiv l−1, and 111.6±17.8 and 168.0±18.1 U l−1, respectively (P<0.0001 for all results). This preliminary study confirmed that tadalafil citrate exerts a beneficial acute effect on the cardiovascular system by reducing serum levels of oxidative stress and increasing serum levels of paraoxonase-1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Frajese GV, Pozzi F . New achievement and novel therapeutic applications of PDE5 inhibitors in older males. J Endocrinol Invest 2005; 28: 45–50.

    CAS  PubMed  Google Scholar 

  2. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Espinoza F, Pons H et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 2005; 68: 2131–2142.

    Article  Google Scholar 

  3. Brindis RG, Kloner RA . Sildenafil in patients with cardiovascular disease. Am J Cardiol 2003; 92: 26–36.

    Article  Google Scholar 

  4. Turgut NH, Temiz TK, Bagcivan I, Turgut B, Gulturk S, Karadas B . The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model. Eur J Pharmacol 2008; 589: 180–187.

    Article  CAS  Google Scholar 

  5. Attina TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ . Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients. J Hypertens 2008; 26: 501–507.

    Article  CAS  Google Scholar 

  6. Zhu B, Strada SJ . The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardio-vascular vessels. Curr Top Med Chem 2007; 7: 437–454.

    Article  CAS  Google Scholar 

  7. Habek M, Petraviæ D . Stroke-an adverse reaction to sildenafil. Clin Neuropharmacol 2006; 29: 165–167.

    Article  CAS  Google Scholar 

  8. Lue TF, Broderick GA . Evaluation of nonsurgical management of erectile dysfunction and premature ejaculation. In: Wein AJ, Kavoussi LR, Novick AJ, Partin AW, Peters CA (eds). Campbell-Walsh Urology, 9th edn. Saunders: Philadelphia, 2007, vol 1, pp 750–787.

    Google Scholar 

  9. Eleuteri E, Magno F, Gnemmi I, Carbone M, Colombo M, La Rocca G et al. Role of oxidative and nitrosative stress biomarkers in chronic heart failure. Front Biosci 2009; 14: 2230–2237.

    Article  CAS  Google Scholar 

  10. Hamilton SJ, Chew GT, Watts GF . Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diab Vasc Dis Res 2007; 4: 89–102.

    Article  Google Scholar 

  11. Perk H, Armagan A, Naziroǧlu M, Soyupek S, Hoscan MB, Sütcü R et al. Sildenafil citrate as a phosphodiesterase inhibitor has an antioxidant effect in the blood of men. J Clin Pharm Ther 2008; 33: 635–640.

    Article  CAS  Google Scholar 

  12. Bivalacqua TJ, Sussan TE, Gebska MA, Strong TD, Berkowitz DE, Biswal S et al. Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. J Urol 2009; 181: 899–906.

    Article  CAS  Google Scholar 

  13. Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G et al. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 2000; 275: 17527–17535.

    Article  CAS  Google Scholar 

  14. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003; 107: 2775–2779.

    Article  CAS  Google Scholar 

  15. Verit FF, Celik H, Yazgan P, Erel O, Geyikli I . Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women. Arch Gynecol Obstet 2007; 275: 353–359.

    Article  CAS  Google Scholar 

  16. Sarandol A, Sarandol E, Eker SS, Karaagac EU, Hizli BZ, Dirican M et al. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1103–1108.

    Article  CAS  Google Scholar 

  17. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN . Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 330–335.

    Article  CAS  Google Scholar 

  18. Erel O . A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103–1111.

    Article  CAS  Google Scholar 

  19. Verit FF, Erel O, Celik N . Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Hum Reprod 2008; 23: 100–104.

    Article  CAS  Google Scholar 

  20. Foresta C, De Toni L, Di Mambro A, Garolla A, Ferlin A, Zuccarello D . The PDE5 inhibitor sildenafil increases circulating endothelial progenitor cells and CXCR4 expression. J Sex Med 2009; 6: 369–372.

    Article  CAS  Google Scholar 

  21. Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Vinanzi C et al. Relationship between vascular damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 expression in the bone marrow. Eur Urol 2007; 51: 1411–1417.

    Article  CAS  Google Scholar 

  22. Jackson G, Montorsi P, Cheitlin MD . Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. Urology 2006; 68: 47–60.

    Article  Google Scholar 

  23. Kontaras K, Varnavas V, Kyriakides ZS . Does sildenafil cause myocardial infarction or sudden cardiac death? Am J Cardiovasc Drugs 2008; 8: 1–7.

    Article  CAS  Google Scholar 

  24. Görge G, Flüchter S, Kirstein M, Kunz T . Sex, erectile dysfunction, and the heart: a growing problem. Herz 2003; 28: 284–290.

    Article  Google Scholar 

  25. Burnett AL, Strong TD, Trock BJ, Jin L, Bivalacqua TJ, Musicki B . Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. J Urol 2009; 181: 245–251.

    Article  CAS  Google Scholar 

  26. Singh U, Jialal I . Oxidative stress and atherosclerosis. Pathophysiology 2006; 13: 129–142.

    Article  CAS  Google Scholar 

  27. De Young L, Yu D, Bateman RM, Brock GB . Oxidative stress and antioxidant therapy: their impact in diabetes-associated erectile dysfunction. J Androl 2004; 25: 830–836.

    Article  Google Scholar 

  28. Speranza L, Franceschelli S, Pesce M, Vinciguerra I, De Lutiis MA, Grilli A et al. Phosphodiesterase type-5 inhibitor and oxidative stress. Int J Immunopathol Pharmacol 2008; 21: 879–889.

    Article  CAS  Google Scholar 

  29. Mackness MI, Durrington PN, Mackness B . The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 2004; 4: 211–217.

    Article  CAS  Google Scholar 

  30. Yildiz A, Gur M, Demirbag R, Yilmaz R, Akyol S, Aslan M et al. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients. Clin Biochem 2008; 41: 779–784.

    Article  CAS  Google Scholar 

  31. Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I . Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients. Med Sci Monit 2008; 14: CR536–CR542.

    PubMed  Google Scholar 

  32. Ciftci H, Yeni E, Savas M, Verit A, Celik H . Paraoxonase activity in patients with erectile dysfunction. Int J Impot Res 2007; 19: 517–520.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, School of Medicine, Harran University, Sanliurfa, Turkey

    A Verit, M Savas, H Ciftci & U Topal

  2. Department of Clinical Biochemistry, School of Medicine, Harran University, Sanliurfa, Turkey

    N Aksoy & A Taskin

Authors
  1. A Verit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Savas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Ciftci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Aksoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Taskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U Topal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Verit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verit, A., Savas, M., Ciftci, H. et al. Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study. Int J Impot Res 22, 115–119 (2010). https://doi.org/10.1038/ijir.2009.58

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2009.58

Keywords

This article is cited by

Search

Advanced search

Quick links